Dexrazoxane

규격

24584-09-6CAS 번호

635-584-1EC 번호

4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dioneIUPAC 명칭

C11H16N4O4화학식

268.27 g/mol분자량

Dexrazoxane; 24584-09-6; ICRF-187; Dextrorazoxane; Dexrazoxano; Dexrazoxanum; ADR-529; Razoxane, d-; Razoxane, (s)-; (+)-(S)-4,4'-Propylenedi-2,6-piperazinedione; 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione; ADR 529; ICRF 187; (+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane; NSC-169780; NSC 169780; CHEBI:50223; 048L81261F; 2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+)-; 4-[(2S)-1-(3,5-dioxopiperazin-1-yl)propan-2-yl]piperazine-2,6-dione; NSC169780; 4-((2S)-2-(3,5-dioxopiperazin-1-yl)propyl)piperazine-2,6-dione; ADR529; 4-((2S)-1-(3,5-dioxopiperazin-1-yl)propan-2-yl)piperazine-2,6-dione; 6-hydroxy-4-((2S)-2-(5-hydroxy-3-oxo-1,2,3,6-tetrahydropyrazin-1-yl)propyl)-2,3,4,5-tetrahydropyrazin-2-one; 6-hydroxy-4-[(2S)-2-(5-hydroxy-3-oxo-1,2,3,6-tetrahydropyrazin-1-yl)propyl]-2,3,4,5-tetrahydropyrazin-2-one; Razoxane (+)-; Soluble ICRF (L-; RefChem:56380; Hydrochloride, Dexrazoxane; ICRF187; V03AF02; Razoxane, (S)-Isomer, Hydrochloride; 2,6-Piperazinedione, 4,4'propylenedi-,(P)-; 2, 6-Piperazinedione, 4,4'-propylenedi-, (P)-; (+)-(S)-4,4'-(1-Methyl-1,2-ethanediyl)di(2,6-piperazinedione); 2,6-Piperazinedione, 4, 4'-(1-methyl-1,2-ethanediyl)bis-, (S)-; 2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-,(S)-; (S)-4,4'-(Propane-1,2-diyl)bis(piperazine-2,6-dione); Zinecard; Dexrazoxanum [INN-Latin]; Dexrazoxano [INN-Spanish]; Dexrazone; 2,6-Piperazinedione, 4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-; Desrazoxane; DTXSID3040647; MFCD00866449; 4,4'-[(1S)-1-Methyl-1,2-ethanediyl]bis-2,6-piperazinedione; (+)-dexrazoxane; 2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (S)-; Razoxanum [INN-Latin]; Razoxana [INN-Spanish]; DTXCID1020647; CAS-24584-09-6; HSDB 7319; (+)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane; 2,6-Piperazinedione, 4,4'-propylenedi-, (+)-; SR-01000883995; BRN 5759131; Soluble ICRF (L-isosomer); Dexrazoxane [USAN:INN:BAN]; Dexrazoxane?; CCRIS 9394; UNII-048L81261F; NCGC00164737-01; Razoxane (+)-form; Dexrazoxane (Standard); DEXRAZOXANE [INN]; DEXRAZOXANE [JAN]; DEXRAZOXANE [HSDB]; DEXRAZOXANE [USAN]; DEXRAZOXANE [VANDF]; CHEMBL1738; DEXRAZOXANE [MART.]; SCHEMBL18400; DEXRAZOXANE [WHO-DD]; MLS006010158; BIDD:GT0068; Dexrazoxane (JAN/USAN/INN); DEXRAZOXANE [EMA EPAR]; 4,4'-(2S)-propane-1,2-diyldipiperazine-2,6-dione; GTPL7330; orb1306016; Dexrazoxane - Bio-X trade mark; Dexrazoxane, >=95% (HPLC); HY-B0581R; WLZ4517; GLXC-07938; RAZOXANE (+)-FORM [MI]; HY-B0581; Tox21_112256; 2, 4,4'-propylenedi-, (+)-; BDBM50586360; EBC-26383; s5651; AKOS015896392; Tox21_112256_1; (+)-1,5-dioxopiperazin-1-yl)propane; CCG-267131; DB00380; DS-1394; FD65001; NCGC00263544-01; NCGC00263544-02; NCGC00263544-07; BD164365; Dexrazoxane, analytical reference material; NCI60_001367; SMR002529680; (S)-(+)-1,5-dioxopiperazin-1-yl)propane; D1994; D4227; NS00073041; D03730; T22305; (S)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane; AB01273932-01; AB01273932-02; AB01273932_03; EN300-7356981; 2,4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-; F093447; Q524995; 2,4,4'-(1-methyl-1,2-ethanediyl)bis-, (S)-; SR-01000883995-1; SR-01000883995-2; SR-01000883995-5; BRD-K07265709-003-01-5; BRD-K07265709-003-03-1; BRD-K07265709-003-04-9; BRD-K07265709-003-05-6; (S)-4,4-(Propane-1,2-diyl)bis(piperazine-2,6-dione); 4,4'-[(2S)-Propane-1,2-diyl]di(piperazine-2,6-dione)동의어